These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 7658311)

  • 21. Effect of short-term recombinant human erythropoietin therapy in the prevention of anemia of prematurity in very low birth weight neonates.
    Yasmeen BH; Chowdhury MA; Hoque MM; Hossain MM; Jahan R; Akhtar S
    Bangladesh Med Res Counc Bull; 2012 Dec; 38(3):119-23. PubMed ID: 23540189
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Does early erythropoietin therapy decrease transfusions in anemia of prematurity?
    Atasay B; Günlemez A; Akar N; Arsan S
    Indian J Pediatr; 2002 May; 69(5):389-91. PubMed ID: 12061670
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of erythropoietin in the anemia of prematurity.
    Doyle JJ
    Semin Perinatol; 1997 Feb; 21(1):20-7. PubMed ID: 9190030
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Enhancement of erythropoiesis by recombinant human erythropoietin in low birth weight infants: a pilot study.
    Shannon KM; Mentzer WC; Abels RI; Wertz M; Thayer-Moriyama J; Li WY; Thompson D; Decelle S; Phibbs RH
    J Pediatr; 1992 Apr; 120(4 Pt 1):586-92. PubMed ID: 1372652
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recombinant human erythropoietin therapy in low-birthweight preterm infants: a prospective controlled study.
    Arif B; Ferhan K
    Pediatr Int; 2005 Feb; 47(1):67-71. PubMed ID: 15693870
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Effects of recombinant human erythropoietin in preterm newborns with infectious diseases].
    de Vasconcelos P Aguiar IF; Krebs VL; Gualandro SF; Silveira PA; Vaz FA
    Rev Assoc Med Bras (1992); 2007; 53(1):90-4. PubMed ID: 17420902
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recombinant human erythropoietin in the treatment of the anemia of prematurity: results of a double-blind, placebo-controlled study.
    Meyer MP; Meyer JH; Commerford A; Hann FM; Sive AA; Moller G; Jacobs P; Malan AF
    Pediatrics; 1994 Jun; 93(6 Pt 1):918-23. PubMed ID: 8190577
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Recombinant erythropoietin in anemia of prematurity: five years later.
    Shannon K
    Pediatrics; 1993 Oct; 92(4):614-7. PubMed ID: 8414840
    [No Abstract]   [Full Text] [Related]  

  • 29. [Recombinant erythropoietin and early preterm neonatal anemia].
    Piasetskaia NM
    Lik Sprava; 1999 Jun; (4):47-51. PubMed ID: 10476641
    [No Abstract]   [Full Text] [Related]  

  • 30. A comparison of oral and intravenous iron supplementation in preterm infants receiving recombinant erythropoietin.
    Meyer MP; Haworth C; Meyer JH; Commerford A
    J Pediatr; 1996 Aug; 129(2):258-63. PubMed ID: 8765624
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Prevention of anemia of prematurity].
    Atanassova V; Ionov M; Rosmanova R; Simov V
    Akush Ginekol (Sofiia); 2009; 48(6):23-6. PubMed ID: 20225493
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of protein intake on erythropoiesis during erythropoietin treatment of anemia of prematurity.
    Brown MS; Shapiro H
    J Pediatr; 1996 Apr; 128(4):512-7. PubMed ID: 8618185
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of blood sampling stewardship and erythropoietin administration in extremely low birth weight infants-a quality improvement non-controlled before-and-after retrospective study.
    Balasubramanian H; Atyalgade M; Garg B; Srinivasan L; Kabra NS; Khapekar S
    Eur J Pediatr; 2021 May; 180(5):1617-1626. PubMed ID: 33464366
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A randomized, controlled trial of the effects of adding vitamin B12 and folate to erythropoietin for the treatment of anemia of prematurity.
    Haiden N; Klebermass K; Cardona F; Schwindt J; Berger A; Kohlhauser-Vollmuth C; Jilma B; Pollak A
    Pediatrics; 2006 Jul; 118(1):180-8. PubMed ID: 16818564
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anaemia of prematurity. Epidemiology, management and costs.
    Meyer MP
    Pharmacoeconomics; 1997 Oct; 12(4):438-45. PubMed ID: 10174310
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Epoetin beta: new indication. Preparation for IV-SC injection: erythrocyte growth factor.
    Prescrire Int; 1998 Feb; 7(33):13-5. PubMed ID: 10183393
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Erythropoietin, protein, and iron supplementation and the prevention of anaemia of prematurity.
    Bechensteen AG; Hågå P; Halvorsen S; Whitelaw A; Liestøl K; Lindemann R; Grøgaard J; Hellebostad M; Saugstad OD; Grønn M
    Arch Dis Child; 1993 Jul; 69(1 Spec No):19-23. PubMed ID: 8346946
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation and Treatment of Anemia in Premature Infants.
    Hasanbegovic E; Cengic N; Hasanbegovic S; Heljic J; Lutolli I; Begic E
    Med Arch; 2016 Dec; 70(6):408-412. PubMed ID: 28210010
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Erythropoietin and prematurity--where do we stand?
    Carbonell-Estrany X; Figueras-Aloy J; Alvarez E
    J Perinat Med; 2005; 33(4):277-86. PubMed ID: 16207112
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Double blind trial of recombinant human erythropoietin in preterm infants.
    Emmerson AJ; Coles HJ; Stern CM; Pearson TC
    Arch Dis Child; 1993 Mar; 68(3 Spec No):291-6. PubMed ID: 8466265
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.